| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e4c066b3d8185874e461e8305530fe4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd4e093cdc7736586aa9bf033427a098 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2022-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aae7b9cc6fb30ff73391ae3917cb3854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9fcf4f9ca081bf00ea8f39d420da263
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27c716c291dd8d24b65be755fa81e1bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59f193397caf745d421a4c4d6c97e913
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37f648e8f835664a79baffcd17558945 |
| publicationDate |
2022-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022186391-A1 |
| titleOfInvention |
Therapeutic agent for hiv infection |
| abstract |
The present invention provides a pharmaceutical composition for use in the reactivation of HIV latent infection, the pharmaceutical composition containing compounds represented by formulae (I)-(VII). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115504992-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115504992-B |
| priorityDate |
2021-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |